Adamis Pharmaceuticals Corp (33) | Business Finance (17)
Browse by Subcategory
Recent Contracts
-
Press Release dated October 4, 2021
(Filed With SEC on October 4, 2021)
-
Asset Purchase Agreement effective as of July 30, 2021, by and among the Registrant, US Compounding, Inc. and Fagron Compounding Services, LLC
(Filed With SEC on August 5, 2021)
-
Promissory Note dated March 15, 2021
(Filed With SEC on April 15, 2021)
-
Description of the Registrant's Capital Stock
(Filed With SEC on April 15, 2021)
-
Underwriting Agreement, dated January 29, 2021, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters named...
(Filed With SEC on January 29, 2021)
-
August 2020 Amendment to Loan Amendment and Assumption Agreement between the Company and Arvest Bank
(Filed With SEC on September 15, 2020)
-
Form of Warrant
(Filed With SEC on February 21, 2020)
-
Underwriting Agreement, dated September 18, 2020, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters...
(Filed With SEC on September 18, 2020)
-
Amended Promissory Note between the Company and Arvest Bank
(Filed With SEC on September 15, 2020)
-
Description of the Registrants Common Stock
(Filed With SEC on June 22, 2020)
-
Promissory Note date April 10, 2020
(Filed With SEC on April 15, 2020)
-
DESCRIPTION OF CAPITAL STOCK
(Filed With SEC on March 30, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on February 21, 2020)
-
Form of Stock Appreciation Rights Agreement for Non-Employee Directors
(Filed With SEC on November 12, 2019)
-
Form of Warrant dated August 5, 2019
(Filed With SEC on November 12, 2019)
-
Form of Warrant
(Filed With SEC on August 1, 2019)
-
Underwriting Agreement, dated August 1, 2019, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters named...
(Filed With SEC on August 1, 2019)
